4.2 Article

The evolution of personalized healthcare and the pivotal role of European regions in its implementation

期刊

PERSONALIZED MEDICINE
卷 18, 期 3, 页码 283-294

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/pme-2020-0115

关键词

european partnership on personalized medicine; healthcare governance; health data; local and regional authorities; local and regional authorities; personalized healthcare; personalized medicine

资金

  1. European Union's Horizon 2020 research and innovation programme [825812]
  2. H2020 Societal Challenges Programme [825812] Funding Source: H2020 Societal Challenges Programme

向作者/读者索取更多资源

Personalized medicine is advancing the healthcare field with the development of data and technology, with various stakeholders playing a key role in its evolution. Policy documents and initiatives from the International Consortium for Personalised Medicine reveal the changing trends among stakeholders in personalized medicine, with regional authorities and stakeholders accelerating towards personalized care. Their involvement is seen as pivotal in the future of personalized medicine.
Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders have joined the race to deliver personalized care and are driving toward what could be termed as the next personalized healthcare. Their role as a key stakeholder in PM is expected to be pivotal.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据